KAILERA THERAPEUTICS INC
Q2 2026 13F Holders
Symbol
KLRA
CUSIP
482931102
Type
Equity
Class
COMMON STOCK
Num filings
102
Total reported value, excl. options
$2.58 B
Compare 2026 Q2 to
2026 Q3
Manager
Report Date
Value ($000)
Shares
Option Type